Skip to main content
. 2023 Dec 12;15(12):697. doi: 10.3390/toxins15120697

Table 5.

Change in the Disability Assessment Scale (DAS) scores for total and each item (PPS).

Visits Liztox® Group Botox® Group p-Value
n Mean ± SD Median
[Min, Max]
n Mean ± SD Median
[Min, Max]
Total
4 weeks 84 −1.19 ± 0.67 −1.00
[−2.00, 1.00]
82 −1.13 ± 0.72 −1.00
[−2.00, 0.00]
0.6045
8 weeks 82 −1.12 ± 0.69 −1.00
[−2.00, 1.00]
79 −1.09 ± 0.72 −1.00
[−2.00, 1.00]
0.6881
12 weeks 81 −1.14 ± 0.68 −1.00
[−3.00, 1.00]
80 −0.85 ± 0.60 −1.00
[−2.00, 1.00]
0.0047 *
Hand hygiene
4 weeks 18 −1.39 ± 0.50 −1.00
[−2.00, 1.00]
17 −1.24 ± 0.66 −1.00
[−2.00, 0.00]
0.5454
8 weeks 18 −1.39 ± 0.61 −1.00
[−2.00, 0.00]
17 −1.12 ± 0.70 −1.00
[−2.00, 0.00]
0.2486
12 weeks 18 −1.39 ± 0.61 −1.00
[−3.00, −1.00]
17 −0.76 ± 0.56 −1.00
[−2.00, 0.00]
0.0048 *
Dressing
4 weeks 2 −1.50 ± 0.71 −1.50
[−2.00, −1.00]
3 −0.67 ± 1.15 0.00
[−2.00, 0.00]
0.5428
8 weeks 2 −1.50 ± 0.71 −1.50
[−2.00, −1.00]
3 −0.67 ± 1.15 0.00
[−2.00, 0.00]
0.5428
12 weeks 2 −1.00 ± 1.41 −1.00
[−2.00, 0.00]
2 −1.00 ± 1.41 −1.00
[−2.00, 0.00]
1.0000
Limb position
4 weeks 61 −1.16 ± 0.69 −1.00
[−2.00, 1.00]
58 −1.16 ± 0.72 −1.00
[−2.00, 0.00]
0.9348
8 weeks 59 −1.05 ± 0.71 −1.00
[−2.00, 1.00]
56 −1.13 ± 0.72 −1.00
[−2.00, 1.00]
0.6246
12 weeks 58 −1.05 ± 0.69 −1.00
[−2.00, 1.00]
57 −0.88 ± 0.60 −1.00
[−2.00, 1.00]
0.1289
Pain
4 weeks 3 −0.33 ± 0.58 0.00
[−1.00, 0.00]
4 −0.75 ± 0.50 −1.00
[−1.00, 0.00]
0.4142
8 weeks 3 −0.67 ± 0.58 −1.00
[−1.00, 0.00]
3 −0.67 ± 0.58 −1.00
[−1.00, 0.00]
1.0000
12 weeks 3 −1.33 ± 0.58 −1.00
[−2.00, −1.00]
4 −0.75 ± 0.50 −1.00
[−1.00, 0.00]
0.2703

Change = week 4, 8, 12—baseline. p-value for comparisons between treatment groups: Wilcoxon rank sum test. * The level of significance was set at p < 0.05